Wednesday, December 23, 2009

Arena Atherosclerosis Drug Trial Ends in Disappointment - San Diego Business Journal


Arena Atherosclerosis Drug Trial Ends in Disappointment
San Diego Business Journal
The news sent shares of Arena, traded under the symbol ARNA on the Nasdaq, down 4 percent in after-hours trading at $3.65. The seven-year collaboration ...

and more »

No comments:

Post a Comment